WASHINGTON, DC (February 13, 2019) — With everyone from patients to the President demanding action on drug pricing, AAM welcomes the re-introduction of the Preserving Access to Cost Effective Drugs (PACED) Act.
The morning after the President's State of the Union address, Health and Human Services Secretary Alex Azar will livestream from AAM's Annual Meeting in New Orleans: Access! 2019.
Tune in on Wednesday, February 6 at 11:15 CST to hear the Secretary detail the Administration's plans to enhance competition to lower drug prices for American patients.
WASHINGTON DC (February 1, 2019) – “AAM applauds the Administration’s efforts to reduce high brand drug costs for patients. Too often, brand drug companies are using rebate traps to block patient access to more affordable generic or biosimilar medicines. We look forward to reviewing the proposal and working with the Administration to ensure that America's patients have access to more affordable generic and biosimilar therapies.”
Safe, reliable generic prescription drugs enable Americans to save money at the pharmacy counter. The government saves big, too, on medicine for seniors and low-income people. In 2017, overall savings came to $265 billion.
AAM’s annual generic drug savings and access report presents the independent findings of IQVIA regarding the savings that our companies bring about, including savings by state.
More FDA-approved generic and biosimilar medicines are available now than ever before. Today, America’s patients are benefitting from significant savings at the pharmacy counter and in lower out-of-pocket costs. But those savings are increasingly at risk due to anti-competitive abuses and misguided policies that block access to lower-cost medicines.
Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.
Rich of Trumbull, Connecticut, counts on generic medicine to stay healthy in his 70's. “There's no question in my mind that generics work," he says. "The doctor explained it was a generic I would be taking, it was no different than the brand and it would be much cheaper. So I said, 'go for it!'” Rich is just one of millions of patients helped every day by the members of the Association of Accessible Medicines, formerly the Generic Pharmaceutical Association.
Jonnie, 57, of Skiatook, Oklahoma, counts on generic medicine to stay healthy. “I've got the gamut of things that could go wrong as you get older,” she explains. “When you pay for a name brand, it's super expensive. [Do] you know what it's like to have a drug that costs your car payment each month? If it weren't for these generic medications, I don't know where my life would be. I can afford things.” Jonnie is just one of millions of patients helped every day by the members of the Association of Accessible Medicines, formerly the Generic Pharmaceutical Association.
Midterm elections changed the political landscape in Washington and across the country. AAM President and CEO Chip Davis invites you to attend Access! 2019 and lend your voice to the conversations and debate in their wake. Learn more at: http://bit.ly/Access2019
Diverse Coalition Says USMCA Violates U.S. Law, Protects Drug Monopolies and Keeps Price of Medicine High, Hurting Patients and American Businesses